Latest news
PharmaCyte Biotech (PMCB) Q1 2026 Earnings: Narrowing Loss Amid Clinical Progress - Healthcare Earnings Report - dars.gov.etdars.gov.et · Fri, 31 Jul 2026 01:34:36 GMTPharmaCyte Biotech, Inc. FY 2026: Revenue $0 Net income ($23.21M), EPS ($2.77) — 10-K Summary - TradingViewTradingView · Wed, 29 Jul 2026 21:05:01 GMTPharmaCyte Biotech, Inc. Reports Earnings Results for the Full Year Ended April 30, 2026 - marketscreener.commarketscreener.com · Wed, 29 Jul 2026 07:00:00 GMT